HoldHigh
4日前
From an article on MJbiz : What cannabis products are available at Georgia pharmacies?
Currently, the state limits business licenses to:
Six cultivation licenses
15 retail licenses, six of which are held by Trulieve
One independent cannabis testing laboratory
But cultivators can also start selling to pharmacies, as Trulieve is doing. According to the company, any independent pharmacy that’s pursued U.S. Drug Enforcement Administration registration as part of medical cannabis’ reclassification as a Schedule 3 drug can sell cannabis products.
Trulieve is supplying cannabis products to more than 12 pharmacies, with plans to expand, the company said Wednesday.
So looks to me GA is the next state TRLV should dominate. Regardless of the DEA hearing outcome TRLV is in a good place. While I do think the DEA will recommend rescheduling of recreational mj, I think there will be some lawsuits to follow, which may take a little time to resolve. I noticed another company is now listed on the NYSE, but they are not near as profitable as TRLV and have a very small footprint at this point, while the stock is trading higher. I don't think that will last, as I predict TRLV will continue it's upward trend.
HoldHigh
1週前
From an article. Most U.S. cannabis firms list in Canada on the Canadian Securities Exchange or trade over-the-counter in the U.S. A NYSE listing offers obvious advantages, including access to deeper-pocketed institutional investors. It also allows millions of retail investors on Robinhood to trade cannabis stocks, where Trulieve and Glass House are available.
But some cannabis companies are waiting out the DEA hearings rather than following Trulieve's path. In other words, their medical-only business is too small to be investable on its own, so they'd rather wait to see if they can list the whole business together.
Trulieve has a large medical cannabis business so they are already benefiting from the rescheduling of medical. It would be icing on the cake to get the other dispensaries and locations now with Harvest, included with this medical, but it will take a positive ruling by the DEA. It really won't affect them if they don't approve rescheduling since most of their dispensaries are medical. Trulieve operates medical marijuana sales in Arizona, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia.
US Market News
2週前
Trulieve Announces Planned Termination of Executive Automatic Securities Disposition PlanJune 26, 2026 4:30 PM
PR Newswire (Canada) TALLAHASSEE, Fla., June 26, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that Ms. Kim Rivers, the Company's Chairman and Chief Executive Officer, has notified the broker dealer administering her automatic securities disposition plan ("ASDP") of her intention to terminate the plan during the Company's next open trading window on August 11, 2026. The ASDP, which was adopted on March 16, 2026, was initiated during an open trading window consistent with the conditions of Rule 10b5-1 under the Securities Exchange Act of 1934. The plan provided for the orderly sale of 2.5 million shares to be sold in two tranches. Sales under the first tranche began on June 17, 2026, with the second tranche sales set to start on September 15, 2026. As of June 26, 2026, the first tranche of share sales totaling 1,699,007 subordinate voting shares has been completed. Ms. Rivers has notified the broker dealer administering the plan of her intention to terminate the plan on August 11, 2026, during the next open trading window, prior to any share sales under the second tranche.Forward-Looking Statements
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from those contained in the forward-looking statements. Risks and uncertainties include, without limitation, the risks and factors discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025 and in our periodic reports subsequently filed with the United States Securities and Exchange Commission and in the Company's filings on SEDAR+ at www.sedarplus.ca. There can be no assurance that any forward-looking statements herein will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.Facebook: @Trulieve
Instagram: @Trulieve
X: @TrulieveInvestor and Media Contact
Christine Hersey, Chief Corporate Affairs & Strategy Officer
+1 (424) 202-0210
Christine.Hersey@Trulieve.com View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-planned-termination-of-executive-automatic-securities-disposition-plan-302812302.htmlSOURCE Trulieve Cannabis Corp. Original: Trulieve Announces Planned Termination of Executive Automatic Securities Disposition Plan
HoldHigh
4週前
From an AI bot.
Trulieve Cannabis Corp. is set to ring the opening bell at the New York Stock Exchange (NYSE) on June 10, 2026. This event marks a significant milestone as Trulieve becomes the first U.S. cannabis company to be listed on a major American exchange.
Significance of the Event
First U.S. Cannabis Company: Trulieve's listing represents a breakthrough for the cannabis industry, which has historically faced challenges in accessing major capital markets.
Opening Bell Ceremony: The ringing of the bell is a traditional event that signifies the start of trading for the day, and it is often attended by company executives and stakeholders.
Background on Trulieve's Listing
Ticker Symbol: Trulieve will trade under the ticker symbol TRLV.
Corporate Restructuring: To comply with NYSE regulations, Trulieve underwent a restructuring that involved spinning off its adult-use cannabis operations, allowing it to focus solely on medical marijuana.
This listing is expected to enhance Trulieve's visibility and liquidity in the market, paving the way for further growth in the cannabis sector.